These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 22890512

  • 41. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.
    G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983177
    [Abstract] [Full Text] [Related]

  • 42. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB, Wazil AWM, Nanayakkara N, Samarakoon SMDK, Senavirathne EMSK, Thangarajah BUEWDR, Karunasena N, Mahanama RMBSS.
    J Med Case Rep; 2020 Jan 13; 14(1):11. PubMed ID: 31928535
    [Abstract] [Full Text] [Related]

  • 43. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
    Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD, Martino M, Sesta M, Di Cuonzo F, Resta MC, Gaeta A, Milella L, Chironna M, Germinario C, Scavia G, Gesualdo L, Giordano M.
    Pediatr Nephrol; 2019 Mar 13; 34(3):517-527. PubMed ID: 30362078
    [Abstract] [Full Text] [Related]

  • 44. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP.
    Transplant Proc; 2012 Dec 13; 44(10):3037-40. PubMed ID: 23195022
    [Abstract] [Full Text] [Related]

  • 45. Life-Threatening Diffuse Alveolar Hemorrhage and Graft Failure in Atypical Hemolytic Uremic Syndrome with C3 Gene Mutation following Kidney Transplant.
    Song JY, Oh SH, Kim Y.
    Nephron; 2024 Dec 13; 148(7):474-479. PubMed ID: 38008090
    [Abstract] [Full Text] [Related]

  • 46. Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.
    Laurence J.
    Clin Adv Hematol Oncol; 2020 Apr 13; 18(4):221-230. PubMed ID: 32628650
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Late renal recovery after treatment over 1 year post-onset in an atypical hemolytic uremic syndrome: a case report.
    Kuroki Y, Mitsuiki K, Nakagawa K, Tsuruya K, Katafuchi R, Hirakata H, Nakano T.
    BMC Nephrol; 2020 Jun 22; 21(1):236. PubMed ID: 32571244
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Improved Renal Recovery with Eculizumab Therapy among Children with High Prevalence of Mutation-Associated Atypical Hemolytic Uremic Syndrome: A Retrospective Cohort Study.
    Bamhraz AA, Rahim KA, Faqeehi HY, Alanazi A.
    Kidney Blood Press Res; 2020 Jun 22; 45(6):939-954. PubMed ID: 33238263
    [Abstract] [Full Text] [Related]

  • 57. Comparison of outcomes after plasma therapy or eculizumab in pediatric patients with atypical hemolytic uremic syndrome.
    Ashida A, Matsumura H, Shimono A, Fujii Y, Yamazaki S.
    Clin Exp Nephrol; 2023 Feb 22; 27(2):161-170. PubMed ID: 36336723
    [Abstract] [Full Text] [Related]

  • 58. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A, Nayer A, Haas CS.
    J Nephrol; 2017 Jun 22; 30(3):347-362. PubMed ID: 27848226
    [Abstract] [Full Text] [Related]

  • 59. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
    Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C, French Study Group for Atypical HUS.
    Am J Transplant; 2012 Dec 22; 12(12):3337-54. PubMed ID: 22958221
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.